Insulin-dependent Tyrosine Phosphorylation of the vav Proto-oncogene Product in Cells of Hematopoietic Origin (*)

Insulin activates the ras signaling pathway and promotes hematopoietic cell proliferation. One possible mediator in such signaling is the vav proto-oncogene product (p95), which is specifically expressed in cells of hematopoietic origin and contains domains typical of guanine nucleotide exchange factors as well as Src homology 2 and Src homology 3 domains. We studied the tyrosine phosphorylation of p95 in hematopoietic cells expressing insulin receptors. Immunoblotting experiments with an antiphosphotyrosine monoclonal antibody disclosed that insulin induces rapid and transient tyrosine phosphorylation of p95 in the human U-266 myeloma cell line. These findings were confirmed by immunoprecipitation experiments performed with P-labeled cells and phosphoamino acid analysis of the bands corresponding to p95. Similarly, insulin-dependent tyrosine phosphorylation of p95 was observed in the human IM-9 and mouse J558L hematopoietic cell lines. Furthermore, insulin treatment of cells led to the association of the Src homology 2 domain of p95 with the activated β-subunit of the insulin receptor in vitro. Altogether, these data suggest that p95 is a substrate for the insulin receptor tyrosine kinase and may be involved in an insulin signaling pathway linking receptor-generated signals to Ras or other GTP-binding proteins in cells of hematopoietic origin.

[1]  A. Weiss,et al.  The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. , 1994, The Journal of biological chemistry.

[2]  C. Der,et al.  Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras , 1994, Molecular and cellular biology.

[3]  O. Hobert,et al.  Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. , 1994, The Journal of biological chemistry.

[4]  M. Barbacid,et al.  Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. , 1994, Oncogene.

[5]  B. Druker,et al.  Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. , 1994, Oncogene.

[6]  J. Olefsky,et al.  Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. , 1994, The Journal of biological chemistry.

[7]  R. Medema,et al.  Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras , 1994, Molecular and cellular biology.

[8]  A. Altman,et al.  Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. , 1994, Journal of immunology.

[9]  L. Platanias,et al.  Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. , 1994, The Journal of biological chemistry.

[10]  A. Wittinghofer,et al.  Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein , 1994, Molecular and cellular biology.

[11]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[12]  M. White,et al.  Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[14]  W. Farrar,et al.  Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. , 1993, The Biochemical journal.

[15]  G. Freund,et al.  Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. , 1993, Journal of immunology.

[16]  A. Cherniack,et al.  Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. , 1993, Science.

[17]  Nanxin Li,et al.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.

[18]  T. Pawson,et al.  The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.

[19]  A. Altman,et al.  Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. , 1993, Science.

[20]  A. Ullrich,et al.  The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.

[21]  G. Lienhard,et al.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Platanias,et al.  Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. , 1992, The Journal of biological chemistry.

[23]  M. White,et al.  IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Barbacid,et al.  Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.

[25]  B. Margolis,et al.  Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation. , 1992, The EMBO journal.

[26]  T. Pawson,et al.  The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. , 1992, The Journal of biological chemistry.

[27]  M. Barbacid,et al.  Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells , 1992, Science.

[28]  T. Lints,et al.  The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.

[29]  A. Ullrich,et al.  Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.

[30]  M. Barbacid,et al.  Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.

[31]  D. Birnbaum,et al.  The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. , 1992, Oncogene.

[32]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[33]  J. Cleveland,et al.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential , 1991, Molecular and cellular biology.

[34]  M. Barbacid,et al.  Mechanism of activation of the vav protooncogene. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[35]  M. Barbacid,et al.  vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.

[36]  B. Sefton,et al.  Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. , 1989, Analytical biochemistry.

[37]  L. Pfeffer,et al.  Interferon-alpha down-regulates insulin receptors in lymphoblastoid (Daudi) cells. Relationship to inhibition of cell proliferation. , 1987, The Journal of biological chemistry.